What This Document Is
This study guide is designed to help students prepare for the first final exam in NR567, Advanced Pharmacology for the AGACNP at Chamberlain University. It focuses on key concepts related to anticoagulation and blood coagulation, providing a concentrated review of essential information for exam success.
Why This Document Matters
This guide is crucial for Advanced Practice Registered Nurses (APRNs) specializing in adult-gerontology acute care. A strong understanding of anticoagulants is vital for managing patients with conditions like atrial fibrillation, venous thromboembolism, and those at risk for stroke or post-operative clots. This resource is intended for use during focused exam preparation, serving as a quick reference to core pharmacological principles.
Common Limitations or Challenges
This study guide is a condensed review and does *not* replace the need for comprehensive study of course materials, textbooks, and clinical guidelines. It is not a substitute for understanding the underlying pathophysiology of coagulation disorders or the nuances of individual patient cases. It also does not include practice questions or detailed case studies.
What This Document Provides
This study guide includes a focused overview of:
* Therapeutic dosing and monitoring parameters for warfarin (Coumadin).
* A comparison of different types of anticoagulants, including their mechanisms of action and appropriate indications for use.
* A breakdown of the blood coagulation cascade, outlining the initial steps of platelet plug formation and subsequent fibrin clot stabilization.
* Detailed tables outlining Indirect Thrombin Inhibitors (Unfractionated Heparin, Low-Molecular-Weight Heparin, Fondaparinux), Warfarin, Oral Direct Factor Xa Inhibitors (Rivaroxaban, Apixaban, Edoxaban), Direct Thrombin Inhibitors (Hirudin, Argatroban, Dabigatran), and Fibrinolytics. These tables cover MOA, Dosage, Monitoring, Clinical Applications, and Toxicities/Reversal agents.
This preview *does not* include the full details of each drug’s pharmacokinetics, detailed adverse effect profiles beyond those listed, or specific patient monitoring algorithms.
